Executive record

Darrin M. Beaupre

Chief Medical Officer at IDEAYA Biosciences, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:darrin-m-beaupre-idyaVersion: public-0As of: 2026-09-30

Not yet claimed9 published Claims3 sources
  • Executive

Key Claims

Biography

Has served as Chief Medical Officer since November 2022, with prior roles as CMO at Biosplice Therapeutics and SVP of Early Oncology Development at Pfizer. Also held positions at Pharmacyclics and Amgen, and taught medicine at the H. Lee Moffitt Cancer Center and University of Miami.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedChief Medical Officer · IDEAYA Biosciences, Inc.
  2. 2026 to end not publishedExecutive title: Chief Medical Officer · Organization not publishedIDYA DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. IDYA DEF 14A executive officers

    sec filing · Source published: Apr 29, 2026 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at IDEAYA Biosciences, Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Chief Medical Officer · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  2. Open source

    sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 6, 2026

    Supports 1 claim
    • Professional Role: Chief Medical Officer at IDEAYA Biosciences, Inc. · Claim reviewed: Sep 6, 2026

  3. IDYA executive roster source

    sec filing · Source published: Date unavailable · Retrieved: May 3, 2026

    Supports 5 claims
    • AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
    • AI governance relevance: AI governance relevance: not identified in the cited filing · Claim reviewed: May 3, 2026
    • Executive company: Executive at IDEAYA Biosciences, Inc. · Claim reviewed: May 15, 2026
    • Executive function: Other Executive (OTHER_EXECUTIVE) · Claim reviewed: May 3, 2026
    • Executive title: Executive title: Chief Medical Officer · Claim reviewed: May 15, 2026